Management of Euglycemic Diabetic Ketoacidosis

被引:0
|
作者
Mathew, Daniya S. [1 ]
Ng, Kimberly E. [2 ]
Jacob, Elsen C. [2 ]
机构
[1] St Johns Univ, Coll Pharm & Hlth Sci, New York, NY 11439 USA
[2] St Johns Univ, Coll Pharm & Hlth Sci, Dept Clin Hlth Profess, New York, NY USA
关键词
INHIBITORS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Euglycemic diabetic ketoacidosis (EDKA) is a rare, acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketoacidosis. Unlike DKA, the diagnosis of EDKA is often overlooked because of the absence of hyperglycemia. The mechanism behind EDKA involves a general state of starvation that results in ketosis while normoglycemia is maintained. EDKA may be associated with precipitating factors, including sodium-glucose cotransporter 2 inhibitors, starvation, pregnancy, alcohol use, surgery, and drug-induced intoxication. A stepwise approach is used in the management of EDKA. Pharmacists can assist the medical team in preventing EDKA and can play a role in the management of EDKA.
引用
收藏
页码:HS1 / HS6
页数:6
相关论文
共 50 条
  • [1] Euglycemic Diabetic Ketoacidosis: How Is It Different from Diabetic Ketoacidosis
    Ju, Hsiao-Hui
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2025, 37 (01) : 157 - 165
  • [2] Diabetic euglycemic ketoacidosis, more iatrogeny?
    Agra Montava, I.
    Seres Roig, M.
    Jodar Manzaneda, V.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (02): : 135 - 136
  • [3] Euglycemic Diabetic Ketoacidosis in the Surgical Patient
    McCabe, David E.
    Strollo, Brian P.
    Fuhrman, George M.
    AMERICAN SURGEON, 2023, 89 (04) : 1083 - 1086
  • [4] Euglycemic diabetic ketoacidosis: A missed diagnosis
    Nasa, Prashant
    Chaudhary, Sandeep
    Shrivastava, Pavan Kumar
    Singh, Aanchal
    WORLD JOURNAL OF DIABETES, 2021, 12 (05) : 514 - 523
  • [5] Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
    Yu, Xiaofang
    Zhang, Saifei
    Zhang, Long
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [6] Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis
    Dizon, Stephanie
    Keely, Erin J.
    Malcolm, Janine
    Arnaout, Amel
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 499 - 503
  • [7] Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report
    Fukuda, Masafumi
    Nabeta, Masakazu
    Muta, Takanori
    Fukami, Kei
    Takasu, Osamu
    INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE, 2020, 13 (01)
  • [8] EUGLYCEMIC DIABETIC KETOACIDOSIS (EDKA) IN A PATIENT RECEIVING DAPAGLIFLOZIN
    Sethi, S. M.
    Vohra, M.
    Ali, S. A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (02) : 266 - 269
  • [9] Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports
    Altowayan, Waleed M.
    ANNALS OF MEDICINE AND SURGERY, 2022, 84
  • [10] EUGLYCEMIC DIABETIC KETOACIDOSIS SECONDARY TO DAPAGLIFLOZIN USE: A CASE REPORT
    Brown, Felicity
    McColl, Tamara
    JOURNAL OF EMERGENCY MEDICINE, 2018, 54 (01): : 109 - 111